Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Cash & Equivalents (2016 - 2025)

Cosmos Health's Cash & Equivalents history spans 13 years, with the latest figure at $15412.0 for Q4 2025.

  • Quarterly results put Cash & Equivalents at $15412.0 for Q4 2025, up 2.29% from a year ago — trailing twelve months through Dec 2025 was $15412.0 (up 2.29% YoY), and the annual figure for FY2025 was $15412.0, up 2.29%.
  • Cash & Equivalents for Q4 2025 was $15412.0 at Cosmos Health, down from $889441.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $20.7 million in Q4 2022 to a low of $15067.0 in Q4 2024.
  • The 5-year median for Cash & Equivalents is $835435.5 (2021), against an average of $2.6 million.
  • The sharpest move saw Cash & Equivalents skyrocketed 7142.8% in 2022, then crashed 99.61% in 2024.
  • Year by year, Cash & Equivalents stood at $286487.0 in 2021, then skyrocketed by 7142.8% to $20.7 million in 2022, then crashed by 81.53% to $3.8 million in 2023, then crashed by 99.61% to $15067.0 in 2024, then increased by 2.29% to $15412.0 in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $15412.0, $889441.0, and $655503.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.